These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19845241)

  • 1. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of digoxin in children with congestive heart failure aggravated by other diseases.
    Lares-Asseff I; Juárez-Olguín H; Flores-Pérez J; Bobadilla-Chávez J
    Rev Invest Clin; 2004; 56(1):32-7. PubMed ID: 15144040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome.
    Xiaoli D; Qiang F
    J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Orio K; Yukawa M; Terao K; Kinoshita H
    J Clin Pharm Ther; 2005 Aug; 30(4):401-5. PubMed ID: 15985054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
    Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of gentamicin in horses.
    Martín-Jiménez T; Papich MG; Riviere JE
    Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.
    Jullien V; Urien S; Hirt D; Delaugerre C; Rey E; Teglas JP; Vaz P; Rouzioux C; Chaix ML; Macassa E; Firtion G; Pons G; Blanche S; Tréluyer JM
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3548-55. PubMed ID: 16940058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.